Ikris Pharma
About Us Named Patient Program
Contact Us

Prescription
Guidelines

Why Is a Prescription Required?

Medicines under the Named Patient Program are supplied on a patient-specific basis and require a valid prescription from the treating physician. This ensures clinical appropriateness and supports regulatory compliance. All prescriptions and supporting documents are reviewed, and where necessary, the prescribing healthcare professional may be contacted for verification or clarification.

Prescription required for Named Patient Program
Doctor with Patient

What Should Your
Prescription Include?

To help ensure timely processing, the prescription should contain the following information:

• Treating Physician Information

The prescribing physician's full name, contact details, professional registration number, and official clinic, hospital, or healthcare institution letterhead.

• Patient Information

The patient's full name, date of birth, diagnosis, and other identifying information required for patient-specific access and regulatory review.

• Medicine & Treatment Details

The prescribed medicine name, strength, dosage form, prescribed dose, treatment duration, quantity required, and relevant treatment instructions, where applicable.

• Prescription Authentication

The date of issue, physician's signature, and official stamp or seal, where applicable.

Patient-Specific Import
Compliance

Medicines supplied through the Named Patient Program are imported on a patient-specific basis and may require supporting documentation in accordance with applicable regulatory requirements. The prescribing physician may be requested to provide clinical justification confirming the medical need for the requested treatment and its intended use for the patient.

Additional documentation may include a medical summary, diagnosis details, treatment history, and confirmation of the prescribed dosage and treatment duration. Accurate and complete documentation helps facilitate regulatory review, supports import authorization procedures, and ensures compliance with patient-specific access requirements.

In India, patient-specific imports are governed by the applicable provisions of the Drugs and Cosmetics Act, 1940 and related regulatory requirements administered by the Central Drugs Standard Control Organization (CDSCO). Depending on the medicine and patient circumstances, additional documentation or approvals may be required to support the lawful import of medicines that are not otherwise commercially available in the country.

Patient Import Compliance

Frequently Asked
Questions

Here are answers to questions we're often asked.

Find your Answers?